Identification of pentosidine as a native structure for advanced glycation end products in β2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis

T. Miyata, S. Taneda, R. Kawai, Y. Ueda, S. Horiuchi, M. Hara, K. Maeda, V. M. Monnier

Research output: Contribution to journalArticlepeer-review

188 Citations (Scopus)

Abstract

β2-Microglobulin (β2m) is a major constituent of amyloid fibrils in patients with dialysis-related amyloidosis (DRA). Recently, we found that the pigmented and fluorescent adducts formed nonenzymatically between sugar and protein, known as advanced glycation end products (AGEs), were present in β2m-containing amyloid fibrils, suggesting the possible involvement of AGE- modified β2m in bone and joint destruction in DRA. As an extension of our search for the native structure of AGEs in β2m of patients with DRA, the present study focused on pentosidine, a fluorescent cross-linked glycoxidation product. Determination by both HPLC assay and competitive ELISA demonstrated a significant amount of pentosidine in amyloid-fibril β2m from long-term hemodialysis patients with DRA, and the acidic isoform of β2m in the serum and urine of hemodialysis patients. A further immunohistochemical study revealed the positive immunostaining for pentosidine and immunoreactive AGEs and β2m in macrophage-infiltrated amyloid deposits of long-term hemodialysis patients with DRA. These findings implicate a potential link of glycoxidation products in long-lived β2m-containing amyloid fibrils to the pathogenesis of DRA.

Original languageEnglish
Pages (from-to)2353-2358
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume93
Issue number6
DOIs
Publication statusPublished - 1996

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Identification of pentosidine as a native structure for advanced glycation end products in β<sub>2</sub>-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis'. Together they form a unique fingerprint.

Cite this